Overall, we believe that our observations, together with the remarkable efforts from other colleagues, have exhausted the possibilities of finding unequivocal, mutation-specific, ETS factors controlling TERT in thyroid cancers, and we caution against the generalization of discrete ETS findings from other tumor lineages. The gene discussed is TERT; the disease is neoplasm.